India’s biotechnology industry is experiencing significant growth driven by innovation and investment, yet it encounters obstacles in scaling up manufacturing and infrastructure. Experts highlight that addressing these bottlenecks is crucial to sustaining momentum and competing globally.
India’s biotech sector grows rapidly but faces challenges in manufacturing scale-up and infrastructure, crucial for sustaining global competitiveness.
India’s biotechnology sector is witnessing remarkable growth as advances in research, increased funding, and a supportive policy environment propel the industry forward. However, despite this surge in momentum, the sector continues to face significant challenges related to scaling manufacturing capabilities and infrastructure development.
The biotech industry in India has expanded rapidly over recent years, leveraging a strong foundation of academic research and burgeoning start-up activity. According to recent industry reports, investments in biotech startups and research initiatives have reached new highs in 2025, reflecting growing confidence in India’s ability to contribute to global biotechnology innovation.
Yet, scaling up from research and small-scale production to large-scale manufacturing remains a persistent bottleneck. Many companies report difficulties in expanding their production facilities due to insufficient access to funding for capital-intensive infrastructure and regulatory complexities. “While we have the scientific expertise and innovative products, scaling manufacturing to meet domestic and international demand is a hurdle that the industry must overcome,” said Dr. Anjali Mehta, a biotech industry analyst.
Policy initiatives by the Indian government have been instrumental in nurturing the biotech ecosystem. Programs designed to promote public-private partnerships, improve regulatory frameworks, and establish biotechnology parks are underway, aiming to ease the transition from research to commercialization. Notably, the Biotechnology Industry Research Assistance Council (BIRAC) continues to play a pivotal role in funding and supporting startups.
Despite these efforts, experts emphasize the need for enhanced infrastructure, streamlined regulatory processes, and increased collaboration among academia, industry, and government agencies. Investment in advanced manufacturing technologies and workforce skill development are also seen as critical factors for overcoming existing scale bottlenecks.
In addition, the global biotechnology landscape is evolving rapidly, with heightened competition from countries investing heavily in biotech innovation and production. India’s ability to sustain its growth trajectory will depend on effectively addressing both internal challenges and external market dynamics.
The momentum in India’s biotechnology sector exemplifies the country’s growing role in global science and technology. However, realizing the full potential of this sector will require strategic investments and coordinated efforts to resolve scalability issues. As the industry navigates these challenges, stakeholders remain optimistic about the future prospects of Indian biotechnology on the world stage.
